Refine by
Biomarker Platform Suppliers & Manufacturers
11 companies found
based inSunnyvale, CALIFORNIA (USA)
Olympia Diagnostics is an In Vitro Diagnostics (IVD) company focusing on development and commercialization of the most advanced breakthrough products for cancer diagnosis and prognosis. We developed a proprietary biomarker discovery platform to ...
based inTaipei City, TAIWAN
Instant NanoBiosensors (INB) is an innovative life sciences company that has developed next generation, ultra-sensitive digital immunoassay platforms that advance precision health for life sciences research and diagnostics. Our platform , Light ...
based inNess Ziona, ISRAEL
BiomX is developing both natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin, as well as harmful bacteria in chronic diseases, such as cystic fibrosis, inflammatory bowel disease, atopic ...
BiomX develops phage cocktails (or combinations) that target and kill specific pathogenic bacteria. Our phage cocktails, which are optimized through algorithms and experimental validation (in-vitro and in-vivo), contain multiple natural and/or ...
based inNotting Hill, AUSTRALIA
INOVIQ Ltd (ASX:IIQ) (INOVIQ) is developing and commercialising an innovative portfolio of diagnostic and exosome-based solutions for the earlier detection, diagnosis, prognosis and monitoring of cancer and other diseases to improve patient outcomes ...
INOVIQ’s NETs technology is a sample preparation platform with the potential to revolutionise the performance of liquid biopsy diagnostic assays. The market potential for liquid biopsy applications is estimated at billions of dollars ...
based inActon, MASSACHUSETTS (USA)
Bluejay Diagnostics, Inc. is developing easy-to-use, near patient medical diagnostics tests. Bluejay Diagnostics is focused on improving patient outcomes through a more cost efficient, rapid, near patient product for triage, diagnosis, and ...
Bluejay Diagnostics is pleased to present Symphony, a near-patient biomarker detection platform. Symphony aims to improve healthcare outcomes by providing quantitative clinical chemistry results, vital for triage ...
based inSherbrooke, QUEBEC (CANADA)
Imeka is currently the only company to combine diffusion imaging and AI to map white matter integrity and get insights on neuroinflammation, demyelination and axonal loss. Therefore, with our non-invasive technology, we minimize risks for our pharma ...
Better Results from Higher Resolution; Any research involving white matter will benefit from our ...
based inWashington, DISTRICT OF COLUMBIA (USA)
We’re pioneering precision neurology by building the world’s leading platform for reliable, accessible, affordable diagnosis and monitoring of neurological diseases. At Altoida, we recognize the need for individuals to understand their brain health ...
based inIrvine, CALIFORNIA (USA)
MDxHealth is a commercial-stage precision diagnostics company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of prostate cancer and other urologic diseases. The Company’s tests are based on ...
based inSan Francisco, CALIFORNIA (USA)
We are a biomarker-guided digital therapeutics company that aims to address complex chronic conditions by embedding a sophisticated biomarker platform into simple, easy-to-use devices. With one simple step, every person can access comprehensive ...
Fully-integrated solution with powerful insights to improve patient ...
based inVancouver, BRITISH COLUMBIA (CANADA)
Augurex develops biomarkers that transform patient clinical management for better disease outcomes by helping diagnose patients, whom when identified can be promptly treated. By biologically informing a clinical assessment, biomarkers optimize ...
Extracellular 14-3-3η protein is a potent ligand and activator of intracellular signalling pathways that lead to the up-regulation of inflammation and joint damage factors involved in RA pathogenesis. The 14-3-3η blood test is clinically ...
based inNedlands, Perth, AUSTRALIA
Proteomics International is a pioneering medical technology company operating at the forefront of predictive diagnostics and bio-analytical services. The Company specialises in the area of proteomics – the industrial scale study of the structure and ...
The ground-breaking prognostic test that can predict the onset of diabetic kidney disease and future kidney function decline in patients with type 2 diabetes. Diabetic kidney disease is the leading cause of chronic and end-stage kidney disease ...